AABB is excited to welcome and announce the participation of Accellix at the inaugural Biotherapies Pavilion during the 2023 AABB Annual Meeting, which will take place Oct. 14-17 in Nashville, Tenn.
FDA awards nearly $7.5 million to pediatric device consortium led by Children’s National Hospital Federal funding fosters the development and commercialization of medical devices designed for children. WASHINGTON, D.C. (Sept.19, [….]
PQE Announcement – PQE Group Opens Office in Montreal, Quebec, Canada
400,000 sf Building Opens Over 90% Leased – Anchored by Penn Medicine and Penn Engineering, and Numerous Commercial Tenants
New Company Launches to Offer Development of Point-of-Care Rapid Immunodiagnostic Lateral Flow Tests San Diego, CA – August 24, 2023 – Gold Colloid, Co., a new company focused on the [….]
Trialogics Opens London Office, Advancing Remote Device Management Services for Clinical Trials WILMINGTON, DELAWARE, Aug. 23, 2023 – Trialogics, a leading clinical trial software and services company, providing eConsent, IRT [….]
Novel Microdevices, Inc. Awarded ~$1.4M from NIH RADx® Tech to Develop a Next-generation, High Performance, Point-of-Care RT-PCR Test.
RTP’s life sciences ecosystem is bouncing back this week with the launch of a new company, Kincell Bio, as well as new financing announcements. Inceptor Bio spins out new company Kincell Bio, which aims to improve accessibility for cell therapy development and manufacturing. RedHill Biopharma and Kriya Therapeutics both announced new funding streams.
Children’s Cancer Foundation Awards went out to 11 pediatric cancer researchers in the Baltimore-Washington region, and a number of companies reported their quarterly finances. It was a busy week for life science news in the Capital Region. Here’s a look.
AsclepiX Therapeutics Raises $10 Million to Advance Phase 1/2a Clinical Study of AXT107